VIR Insider Trading Activity and SEC Form 4 Filings
VIR insider trading summary
Over the past 12 months, insiders at Vir Biotechnology, Inc. (VIR) reported 35 sales worth $17.9M by 10 insiders and no open-market purchases on SEC Form 4. Net insider selling was $17.9M.
Latest VIR insider buys and sells
| Date | Insider | Role | Type | Value |
|---|---|---|---|---|
| Nov 3, 2026 | Verneuil Vanina de | EVP, General Counsel, Corp Sec | Sell | $27K (2,407 @ $11.10) |
| Nov 2, 2026 | Verneuil Vanina de | EVP, General Counsel, Corp Sec | Sell | $15K (1,343 @ $11.33) |
| Jun 1, 2026 | Brent Sabatini | SVP, Chief Accounting Officer | Sell | $4K (379 @ $9.45) |
| Jun 1, 2026 | Janet Napolitano | Director | Sell | $30K (3,200 @ $9.45) |
| May 1, 2026 | Vicki L Sato | Director | Sell | $221K (22,000 @ $10.05) |
| Apr 6, 2026 | Backer Marianne De | President and CEO | Sell | $664K (72,559 @ $9.16) |
| Apr 1, 2026 | Vicki L Sato | Director | Sell | $200K (22,000 @ $9.07) |
| Mar 23, 2026 | Brent Sabatini | SVP, Chief Accounting Officer | Sell | $70K (7,711 @ $9.12) |
| Mar 2, 2026 | Vicki L Sato | Director | Sell | $2K (200 @ $9.98) |
| Mar 2, 2026 | Vicki L Sato | Director | Sell | $207K (21,800 @ $9.50) |
Source: SEC Form 4 filings. Open-market purchases (code P) and sales (code S) only; option exercises, grants and gifts are excluded.